Ono Pharmaceutical Co Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Ono Pharmaceutical Co Ltd and you would like to use your ESG rating, please get in touch. The article includes a questions and answers section about Ono Pharmaceutical Co Ltd. Alternative corporations in the rating industry group for Ono Pharmaceutical Co Ltd are shown below.
Ono Pharmaceutical Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.7; made up of an environmental score of 7.0, social score of 8.0 and governance score of 8.0.
7.7
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 1 | Xlife Sciences AG | 8.0 | High |
| 1 | Zim Laboratories Ltd | 8.0 | High |
| 140 | Ono Pharmaceutical Co Ltd | 7.7 | High |
| 140 | Novartis AG | 7.7 | High |
| 140 | Pfizer Inc | 7.7 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Ono Pharmaceutical Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd offer flexible work?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose water use targets?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Ono Pharmaceutical Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Ono Pharmaceutical Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Ono Pharmaceutical Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Ono Pharmaceutical Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Ono Pharmaceutical Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Ono Pharmaceutical Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors. The company also provides GLACTIV and FORXIGA tablets for type 2 diabetes; FORXIGA tablets for the treatment of diabetes; ONOACT injections for tachyarrhythmia; OPALMON tablets to treat peripheral circulatory disorder; CORALAN for treatment of chronic heart failure; ORENCIA injections for rheumatoid arthritis; RIVASTACH patches for Alzheimer's disease; ONGENTYS tablets for the treatment of Parkinson's disease; PARSABIV, an intravenous injection for dialysis patients; STAYBLA tablets for overactive bladder; ONON capsules and dry syrups for bronchial asthma and allergic rhinitis; and JOYCLU intra-articular injection for the improvement of joint function, as well as RECALBON tablets for osteoporosis. In addition, it is developing products for esophageal, urothelial carcinoma, Hodgkin's lymphoma, ovarian, bladder, prostate, hepatocellular carcinoma, pancreatic, biliary tract, virus positive/negative solid carcinoma, gastric, esophageal, urothelial, hepatocellular, thyroid, colorectal, melanoma, acute myeloid leukemia, non-small cell lung cancer, primary central nervous system lymphoma, myelodysplastic syndrome, polymyositis/dermatomyositis, tachyarrhythmia, pemphigus, generalized scleroderma, enthesopathy, diabetic polyneuropathy, neurodegenerative, autoimmune, narcolepsy, and thrombosis. The company was founded in 1717 and is headquartered in Osaka, Japan.